Bentley Systems Announces Generative AI Game-Changer for Civil Site Design
Company unveils first-to-market AI-powered civil engineering application that delivers optimized, accurate site designs up to 10 times faster than traditional methods
Bentley Systems’ Year in Infrastructure 2024 –Bentley Systems, Incorporated (Nasdaq: BSY), the infrastructure engineering software company, today announced new generative AI capabilities for civil site design, including a design copilot, site layout optimizations, and automated drawing production that will drive new levels of productivity and accuracy.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241009012509/en/
Bentley’s OpenSite+ software uses AI to automate annotation and plan production for civil site design. (Photo: Bentley Systems)
Building on its success in applying AI-powered digital twins to asset maintenance—to detect and assess problems before failures occur—Bentley is bringing AI to the design phase of the infrastructure lifecycle to automate repetitive tasks, such as drawing production, so that engineers can focus on higher-value activities.
Putting AI into Action—Introducing OpenSite+
Bentley’s OpenSite+ is the first engineering application leveraging generative AI for civil site design. It helps engineers swiftly design residential, commercial, and industrial sites with AI tools, significantly boosting productivity and accuracy.
A digital twin-native product, built with Bentley’s iTwin platform, OpenSite+ delivers AI-powered efficiencies and better-quality designs with:
- Enhanced Design Experience with Copilot: Users can quickly create, revise, and interact with requirements documentation and 3D site models through natural language interactions—to automatically make real-time design changes with precision and ease.
- Layout Optimization: Users can enhance efficiency, reduce errors, and rework site designs in minutes with one-click earthwork optimization. Bentley’s AI-powered design layout agent can evaluate thousands of layout options and suggest alternative designs in real-time, helping users make better design decisions sooner, saving time and money.
- Automated Drawing Production: Users can reduce time spent on mundane drawing tasks, accelerating drawing production by up to 10 times, and improve drawing accuracy using AI-powered annotation, labeling, and sheeting that automatically places labels and dimensions according to organizational standards that are optimized for legibility and aesthetics.
- Smart Design Tools: Users can create and revise designs using intelligent, editable objects such as building pads, parking layouts, driveways, sidewalks, and ponds to complete projects in a fraction of time compared to traditional CAD software.
With OpenSite+, users also maintain control over their proprietary data during AI training, which creates a solid foundation to responsibly guide the development of AI models.
“By leveraging their past data to optimize future work, generative AI will revolutionize infrastructure design, improving engineers’ productivity and accuracy without sacrificing on quality,” said Mike Campbell, chief product officer at Bentley Systems. “OpenSite+ is just the first example of how Bentley is applying generative AI to benefit infrastructure design and project delivery.”
OpenSite+ early adopter, Joe Viscuso, senior vice president and director of Strategic Growth at Pennoni, commented, "OpenSite+ is a game-changer. By combining design and routine tasks into one powerful platform, it eliminates the need to switch between multiple programs. It streamlines our workflow, automates repetitive tasks, and ensures accuracy as we make changes in real-time. This means faster project completion with superior results, helping Pennoni stay ahead of the curve in both technology and innovation."
OpenSite+ is the first of a new generation of Bentley Open Applications which run on desktops for optimal responsiveness, while offering the benefits of cloud-based applications, such as automatic updates and cross-operating system availability. The iTwin-native architecture enables seamless collaboration and data-centric workflows. Data is saved directly in a digital twin, which in turn can include data from other sources to provide full context for design work.
Availability
North American site engineering firms can apply for early access.
# # #
About Bentley Systems
Bentley Systems (Nasdaq: BSY) is the infrastructure engineering software company. We provide innovative software to advance the world’s infrastructure – sustaining both the global economy and environment. Our industry-leading software solutions are used by professionals, and organizations of every size, for the design, construction, and operations of roads and bridges, rail and transit, water and wastewater, public works and utilities, buildings and campuses, mining, and industrial facilities. Our offerings, powered by the iTwin Platform for infrastructure digital twins, include MicroStation and Bentley Open applications for modeling and simulation, Seequent’s software for geoprofessionals, and Bentley Infrastructure Cloud encompassing ProjectWise for project delivery, SYNCHRO for construction management, and AssetWise for asset operations. Bentley Systems’ 5,200 colleagues generate annual revenues of more than $1 billion in 194 countries.
© 2024 Bentley Systems, Incorporated. Bentley, the Bentley logo, Bentley Open, iTwin, and OpenSite+ are either registered or unregistered trademarks or service marks of Bentley Systems, Incorporated or one of its direct or indirect wholly owned subsidiaries.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241009012509/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vertex Announces US FDA Approval of ALYFTREK™,a Once-Daily Next-in-Class CFTR Modulator for the Treatment of Cystic Fibrosis20.12.2024 21:46:00 CET | Press release
- ALYFTREK™ is approved for patients 6 years and older with at least one responsive mutation, including 31 additional mutations not responsive to other CFTR modulator therapies - - In head-to-head clinical trials, ALYFTREK was non-inferior on ppFEV1 and further decreased sweat chloride compared to TRIKAFTA® - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has approved ALYFTREK (vanzacaftor/tezacaftor/deutivacaftor), a once-daily next-in-class triple combination cystic fibrosis transmembrane conductance regulator (CFTR) modulator for the treatment of cystic fibrosis (CF) in people 6 years and older who have at least one F508del mutation or another mutation in the CFTR gene that is responsive to ALYFTREK. See below for Important Safety Information, including a Boxed Warning. “ALYFTREK is our fifth CFTR modulator to secure FDA approval and represents another significant milestone in our journey to serially innovate and t
Vertex Announces U.S. FDA Approval for TRIKAFTA (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to Include Additional Non-F508del TRIKAFTA-Responsive Variants20.12.2024 21:35:00 CET | Press release
- Approximately 300 more people with cystic fibrosis in the U.S. are now eligible for a medicine that treats the underlying cause of their disease for the first time - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) has approved the expanded use of TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) for the treatment of people with cystic fibrosis (CF) ages 2 and older who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene or a mutation that is responsive to TRIKAFTA based on clinical and/or in vitro data. In addition, safety information on liver injury and liver failure has been updated from warnings and precautions to a boxed warning. With this approval, 94 additional non-F508delCFTR mutations have been added to the TRIKAFTA label, and approximately 300 additional people with CF in the U.S. are now eligible for a medicine to treat the underlying cause of their
HSBC Continental Europe Enters Into a Memorandum of Understanding Regarding Potential Sale of HSBC Assurances Vie (France) to Matmut Société d’Assurance Mutuelle20.12.2024 20:32:00 CET | Press release
Regulatory News: HSBC Continental Europe has signed a Memorandum of Understanding (‘MOU‘) regarding the potential sale of its French life insurance business, HSBC Assurances Vie (France), to Matmut Société d’Assurance Mutuelle (‘Matmut’) (the “Potential Transaction”). HSBC Assurances Vie (France) provides a wide range of life insurance solutions and services, with over 20 billion euros of outstanding assets, net income1 of 77 million euros and a Solvency II ratio of 287% in 2023. As part of the Potential Transaction, HSBC Continental Europe and Matmut would enter into a long-term arrangement for HSBC Global Asset Management (France) to continue to partner with HSBC Assurances Vie (France). HSBC Assurances Vie (France) will continue its existing distribution arrangements. The Potential Transaction would provide customers and employees of HSBC Insurance Life (France) with the opportunity to join one of the leading French mutual insurance groups, which is in full development, and forms pa
Andersen Global udvider sin ekspertise med tilføjelsen af Valora20.12.2024 17:07:00 CET | Pressemeddelelse
Andersen Global fortsætter sin udvidelse af servicetilbud gennem en samarbejdsaftale med Valora, der er en uafhængig virksomhed med speciale i levering af skræddersyede løsninger til både private og institutionelle kunder globalt. Valora har kontorer i Miami og Raleigh og desuden global tilstedeværelse i Den Dominikanske Republik, Storbritannien og Caymanøerne. Valora blev grundlagt i 2011 af partneren Luis de Leon og tilbyder et stort udvalg af tjenester, blandt andet værdiansættelse, performance, regnskab og administration, global enhedsstyring, fondsvirksomhed og andre skræddersyede løsninger. "Et samarbejde med Andersen passer godt til både vores kunder og vores team," siger Luis. "Synergierne mellem for vores servicetilbud vil sætte os i stand til at levere omfattende og integrerede løsninger med stadigt stigende global rækkevidde." Global Chairman og CEO for Andersen Mark L. Vorsatz udtaler: "Valoras team og virksomhedskultur er, sammen med deres fokus på det praktiske, et godt m
SBC Medical Group Co., Ltd. Sells Two Subsidiaries20.12.2024 13:00:00 CET | Press release
On December 17, 2024, SBC Medical Group Holdings Incorporated (“SBC Medical”, or the “Company”), announced that its subsidiary, SBC Medical Group Co., Ltd. (hereinafter referred to as "SBCMG"), has decided to sell all shares of its subsidiaries, SBC Kijimadaira Resort Co., Ltd. (hereinafter referred to as "Kijimadaira") and Skynet Academy Co., Ltd. (hereinafter referred to as "SNA"), as outlined below. The decision to sell these subsidiaries was made to concentrate SBCMG's management resources on its core medical services business, in line with its strategy of prioritizing and focusing on key business areas. The subsidiaries being sold operate in the following industries: Kijimadaira: Ski resort operations SNA: Flight training operations The shares will be sold to a company wholly owned by Yoshiyuki Aikawa, the CEO of the Company. Since this transaction constitutes a related party transaction, it was deliberated and approved by the Company’s Board of Directors and Audit Committee. To e
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom